Navigation Links
Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology.
Date:5/16/2008

POMPEY, France, May 16 /PRNewswire/ -- Chromatide and Novasep have extended their partnership to develop large scale solid phase peptide and oligonucleotide synthesis technology. The resulting systems and equipment will meet the growing needs of biotechnology and pharmaceutical industries for more efficient, continuous flow instruments for gram to industrial scale production of high quality products.

The interest of this partnership is to combine Chromatide's experience in solid phase synthesis of peptide and oligonucleotides, including the production of novel resins and instrumentation, to Novasep' s expertise in synthesis and purification services and technologies in the biotechnology and pharmaceutical industries to provide them with efficient solutions to obtain pure peptides and oligonucleotides.

Commenting on the announcement, Dr Don Wellings, Chromatide's CSO, said, "We are delighted to be continuing to work with Novasep on this project," He added, "The extension of our collaboration is illustrative of the success we have achieved to date on developing the synthesis systems which Novasep is launching in 2008. Novasep is a world leader in the market with well established relationships within the biotechnology and pharmaceutical sectors which will enable users' rapid access to the technology we are co-developing."

Mr Jean Blehaut, President of Novasep Process Pharma Business Unit added, "The Chromatide team has many years experience in peptide and oligonucleotide synthesis and has excellent contacts with key thought leaders in this field and Novasep is the recognised leader of large scale chromatography for the life-sciences industries. Peptide manufacturers lack a cost efficient, automated solid phase synthesis technology, fully scalable from g to ton. We believe that these innovative systems combined with our chromatography and membrane technology portfolio will allow us to provide a unique, global process solution for peptides but
'/>"/>

SOURCE Groupe Novasep SAS
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Groupe Novasep to Acquire PharmaChem Technologies (Grand Bahama) Ltd
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
4. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
5. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
6. ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating
7. Data from Two Pivotal Trials of AMRIX, a New Once-Daily Extended-Release Muscle Relaxant, Presented at the American Academy of Pain Medicine Meeting
8. DiObex and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release Technology
9. New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition
10. Actress Aida Turturro Tells Americans to Start Now to Talk With Their Healthcare Provider About Taking Control of Their Diabetes
11. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 zFlo Motion , a US ... an exciting product from a new partner. STT-Systems ... the past 15 years, with offerings in the optical-motion capture, ... IMU system (inertial measurement unit), iSen, is opening eyes around ...
(Date:1/22/2015)... 2015 Controlled Substance Compliance Services (CSCS), ... companies check the legal requirements around using controlled substances ... , As their international operations expand and become ... solutions built as a result of the first phase ...
(Date:1/22/2015)... January 22, 2015 Diagenode, Inc., ... as the Bioruptor® and complete solutions for epigenetics ... chromatin immunoprecipitation, alleviating the need for manual processing. ... needed for ChIP of histones or transcription factors ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015   ... company, and Sequenom, Inc. (NASDAQ: SQNM ... a development agreement for next generation noninvasive prenatal ... Cypher,s genome interpretation technology, called Mantis™, to advance ...
Breaking Biology Technology:3D Motion Capture Just Got Easy 2Global Compliance Service for Controlled Substances to Expand to China 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4
... Pharmasset, Inc. (Nasdaq: VRUS ) announced today ... the FDA on the final design for a phase 2b ... slated to initiate in the first quarter of this year."We ... 2b trial," stated Michelle Berrey, MD, MPH, Pharmasset,s Chief Medical ...
... Special Meeting to Enable Stockholders to Determine Fate ... Inc. Offers Avigen Stockholders Extraordinary Risk/Reward OpportunitySAN FRANCISCO, ... with its affiliates ("BVF") today announced that it ... Avigen, Inc. ("Avigen") (Nasdaq: AVGN ) ...
... VANCOUVER, Jan. 9 /PRNewswire/ - Sirius Genomics, a ... has signed a collaborative agreement with the United ... focuses on the continued development of Sirius, pharmacogenomic ... (sold by Eli Lilly and Company under the ...
Cached Biology Technology:Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 2Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 3Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 4Pharmasset and Roche Obtain FDA Consent to Start a Phase 2b Study With R7128 in Treatment Naive HCV Patients 5Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 2Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 3Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 4Biotechnology Value Fund, L.P. Calls Special Meeting of Avigen Stockholders To Remove Incumbent Directors and Elect Slate of Stockholder-Focused Nominees 5Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group 2
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... the "Samsung Galaxy S5 - Home Button Synaptics ... http://photos.prnewswire.com/prnh/20130307/600769 ... iPhone 5S, Samsung introduces for the first time a ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally transforming ... than at international borders. Over the past decade, ePassports, ... travelers to self process through border control via eGates ... number of airports, seaports, and land borders across the ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ...
Breaking Biology News(10 mins):Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2New telemetry implants expected to change how large animal toxicology studies are conducted 2
... University of California, Santa Cruz, who pioneered the use of ... compiled one of the largest datasets available for any marine ... in unprecedented detail. A new study published May ... the annual migrations of adult female elephant seals, with data ...
... Inc. (NASDAQ: AWRE ), a global provider ... it is providing biometrics software and services for three ... team-based project wins in Europe, the Middle East, and ... provide system integrators with a full suite of COTS ...
... drug made from the saliva of the Gila monster ... Researchers at the Sahlgrenska Academy, University of Gothenburg, have ... their cravings for both food and chocolate. An ... are offered a pharmaceutical preparation called Exenatide, which helps ...
Cached Biology News:Elephant seal tracking reveals hidden lives of deep-diving animals 2Elephant seal tracking reveals hidden lives of deep-diving animals 3Aware Provides Biometrics Software and Services for Three Large-Scale Border Management Systems 2Aware Provides Biometrics Software and Services for Three Large-Scale Border Management Systems 3Drugs from lizard saliva reduces the cravings for food 2
geminin, DNA replication inhibitor...
Normal human serum, single donor...
One-step, microplate or cuvet, colorimetric, linear detection range 0.1 mg/dL to 100 mg/dL. Procedure: 20 min....
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
Biology Products: